Form 4: Core Scientific CEO Acquires Shares and Warrants in Recent Transaction
SEC Form 4 Filing
CEO Adam Taylor Sullivan acquired shares and warrants of Core Scientific, Inc. in a transaction dated August 16, 2024.
Summary
- On August 16, 2024, Adam Taylor Sullivan, the CEO of Core Scientific, Inc., acquired 95,303 shares of common stock at a price of $0.01 per share.
- Sullivan also disposed of 4,057,579 shares of common stock.
- Additionally, Sullivan acquired 95,303 Tranche 2 warrants with an exercise price of $0.01.
- These warrants became exercisable on July 11, 2024, and expire on January 23, 2029.
- The warrants allow the holder to purchase one share of common stock when the volume weighted average price equals or exceeds $8.72 for 20 consecutive trading days.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects standard insider trading activity. The acquisition of shares and warrants is balanced by the disposal of a larger number of shares.
Negatives
- The disposal of 4,057,579 shares by the CEO could be interpreted negatively by the market.
Risks
- The exercise of the warrants is contingent on the stock price reaching $8.72 for 20 consecutive trading days, which may not occur.
Future Outlook
The future exercise of the warrants depends on Core Scientific's stock price performance.
Industry Context
Form 4 filings are standard disclosures for company insiders and provide transparency into their trading activities, which can influence investor sentiment.
Stakeholder Impact
- Shareholders may react to the CEO's trading activity, potentially influencing the stock price.
- Employees may be affected by the perceived confidence or lack thereof in the company's future prospects based on the CEO's actions.
Key Dates
| Date | Description |
|---|---|
| April 3, 2024 | The Reporting Person received 95,303 Tranche 2 Warrants for no consideration in connection with an in-kind distribution by XMS Capital Partners, LLC. |
| July 11, 2024 | The Tranche 2 Warrants became exercisable at the option of the registered holders. |
| August 16, 2024 | Date of transaction: acquisition of common stock and Tranche 2 warrants, and disposition of common stock. |
| August 20, 2024 | Date of signature for the Form 4 filing. |
| January 23, 2029 | Expiration date of the Tranche 2 Warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.